Mia's Feed
Medical News & Research

European Launches New Toolkit to Combat Hepatitis in Prisons

European Launches New Toolkit to Combat Hepatitis in Prisons

Share this article

A new European toolkit promotes strategies to eliminate hepatitis B and C in prisons, enhancing health equity and public health safety across Europe.

2 min read

The European Centre for Disease Prevention and Control (ECDC) has introduced a comprehensive new toolkit aimed at eliminating hepatitis B and C within prison settings across Europe. This initiative emphasizes the principle of 'equivalence of care,' ensuring that incarcerated individuals receive health services comparable to those available to the general population. Prisons often exhibit higher rates of viral hepatitis due to increased exposure to risk factors such as injecting drug use, unsafe tattooing, piercing practices, sharing razors, and unprotected sex.

Addressing viral infections in prisons is crucial because many inmates experience multiple incarcerations and cycle between incarceration and community living. Untreated hepatitis in prisons not only affects individuals but also has broader public health implications, as it can lead to transmission in the wider community—a concept known as the 'community dividend.'

The toolkit is organized into four main sections: background information, strategy development, implementation, and monitoring and evaluation. It offers links to public health guidelines and practical tools for understanding the prison environment, defining elimination strategies, and deploying interventions. Case studies from countries such as Germany, Spain, France, Italy, and Luxembourg illustrate successful models of care.

Evidence-based guidance from EUDA and ECDC provides healthcare professionals with actionable strategies to prevent and control viral hepatitis in correctional facilities. The toolkit's insights are also highly relevant for policymakers, security personnel, peer support workers, and voluntary organizations involved in prison health. Upcoming training sessions by EUDA and ECDC will help facilitate effective implementation and service expansion.

This initiative underscores the importance of targeted intervention in high-risk populations to achieve broader public health goals, ultimately reducing the disease burden in both prison and community populations.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Jawbone Organoids from Patient-Derived iPS Cells Advance Bone Disease Research and Treatments

A groundbreaking study from Kyoto University introduces jawbone-like organoids derived from patient iPS cells, enabling advanced research into bone diseases and regenerative therapies, including models for osteogenesis imperfecta.

Innovative Cyclic Disulfide Lipids Show Promise in Halting Cancer Growth in Mice

Nagoya University researchers have created cyclic disulfide lipids that dramatically enhance mRNA delivery, showing promise in stopping tumor growth in mice and advancing cancer vaccine development.

Innovative Brain-on-a-Chip Technology Sheds Light on How Sepsis and Neurodegenerative Diseases Harm Brain Health

Groundbreaking brain-on-a-chip models are advancing our understanding of how systemic inflammation and neurodegenerative diseases damage the brain, paving the way for new treatments and personalized medicine.

Certain Metals and Sulfates in Air Pollution May Significantly Increase Asthma Hospitalizations

New research identifies nickel, vanadium, and sulfate particles in air pollution as key factors increasing asthma hospitalization risks. Targeted pollution control can reduce severe asthma attacks.